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Abstract
Background: I na d u l tl i v e r ,t h em e s e n c h y m a lc e l l s ,p o r t a l fibroblasts and vascular smooth muscle
cells can transdifferentiate into myofibroblasts, and are involved in portal fibrosis. Differential
expression of markers, such as alpha-smooth muscle actin (ASMA), h-caldesmon and cellular
retinol-binding protein-1 allows their phenotypic discrimination. The aim of our study was to
explore the phenotypic evolution of the mesenchymal cells during fetal development in normal
liver and in liver with portal fibrosis secondary to ductal plate malformation in a series of Meckel-
Gruber syndrome, autosomal recessive polycystic kidney disease and Ivemark's syndrome.
Results: At the early steps of the portal tract maturation, portal mesenchymal cells expressed
only ASMA. During the maturation process, these cells were found condensed around the biliary
and vascular structures. At the end of maturation process, only cells around vessels expressed
ASMA and cells of the artery tunica media also expressed h-caldesmon. In contrast, ASMA positive
cells persisted around the abnormal biliary ducts in fibrous livers.
Conclusion: As in adult liver, there is a phenotypic heterogeneity of the mesenchymal cells
during fetal liver development. During portal tract maturation, myofibroblastic cells disappear in
normal development but persist in fibrosis following ductal plate malformation.
Introduction
In the liver, different fibrocompetent cells have been
described in accordance with their topography, their
morphology and their main functions: portal fibroblasts
and vascular smooth muscle cells in the portal tract; hepatic
stellate cells (HSC) and "second layer cells" around the
centrolobular veins in lobular area (review in Guyot et al
[1]). The heterogeneity of these fibrocompetent cells is
characterised by the expression of different markers. For
example, quiescent HSC express cellular retinol-binding
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Open Accessprotein-1 (CRBP-1) but not alpha-smooth muscle actin
(ASMA)orh-caldesmon[2-5].Vascularsmoothmusclecells
expressed ASMA and h-caldesmon [6]. Finally, portal
fibroblasts expressed neither ASMA nor CRBP-1, but
expressed vimentin [3,4]. Myofibroblasts are absent in the
normalliverbut,duringliverfibrosis,thesecellscanacquire
a myofibroblastic phenotype, notably by the expression of
ASMA [1,7].
The phenotypic evolution of mesenchymal cells during
the fetal human liver development has not been studied
with the markers discussed above. The mesenchymal
cells derived from the stroma of the septum transversum
which is invaded by epithelial cell clusters from hepatic
diverticulum during the 4
th week of development (WD)
[8]. The lobulation of the fetal liver begin near the liver
hilum at the 9
th WD, and progresses from the hilum to
the periphery of the liver until at about 1-month post
partum. Concerning the future lobular area, HSC and the
second layer cells around the centrolobular veins, derive
from mesenchymal cells, as well as the mesenchymal
vessels which formed the primitive hepatic sinusoids
[9,10]. Concerning the portal tract, its centrifugal
development is closely associated with intra-hepatic
biliary tree development [11]. Depending exclusively
on the location of the portal tract along the portal tract
tree, between the hilum and the periphery, the sequence
of maturation of a portal tract schematically comprises 3
stages [12]: 1) At the ductal plate stage, segments of
double-layered cylindrical or tubular structures, called
ductal plate, outlined the future portal tract. The future
portal tract contains also large portal vein branch and
limited stroma; 2) At the ductal plate remodelling stage,
the tubular structures become incorporated into the
stroma surrounding the portal vein branch and the rest
of the ductal plate involutes. Arterial branches are also
present; 3) At the remodelled stage, the portal tract is
mature: it contains a branch of the portal vein, two
branches of the hepatic artery and two bile ducts [13]. In
cases of ductal plate malformation, notably observed in
Ivemark's renal-hepatic-pancreatic dysplasia or Ivemark's
dysplasia syndrome type II (IDS2), in Meckel-Gruber
syndrome (MKS) and in autosomal recessive polycystic
kidney disease (ARPKD), the portal tract was deeply
modified [14-16]. It was characterised by portal tract
fibrosis, more mesenchymal cells with ASMA expression
and increased number of arteries [11,17].
The aims of our study were to follow principally the
ASMA, h-caldesmon, CRBP-1 expression of mesenchy-
mal cells during the normal development of the fetal
liver and to explore the phenotypic evolution of the
portal tract mesenchymal cells during the abnormal
development of fetal liver presenting fibrosis following
ductal plate malformation.
Results
Normal fetal liver – Histology
In all tissue samples, the fetal liver tissues showed
anastomosing sheets of fetal hepatocytes. Each sheet,
being two or several cells in thickness, was separated
from the others by capillaries. Haematopoiesis was
present in all cases and prominent in the capillary
lumen or in the Disse space after 12 WD. After 11 WD,
future portal tracts appeared in the parenchyma and
developed with a centrifugal manner from the hilum to
the periphery of the liver. Depending on the tissue
section level (near the hilum or at the periphery), the 3
portal tract maturation stages (described above) were
present. In the parenchyma, future centrolobular veins
with a thin wall were present.
Normal fetal liver – Immunohistochemistry
Alpha-smooth muscle actin (ASMA)
At the ductal plate stage, all fusiform cells in the stroma
between endothelial cells of the future portal vein and
the first plate of hepatoblasts expressed ASMA (Figure 1).
At the remodelling stage (Figure 2), in addition with
fusiform cells under the endothelium of the portal vein
and cells in the tunica media of arteries, fusiform cells
around the tubular biliary structures enmeshed in the
portal stroma and the fusiform cells close to the ductal
plate remnants expressed ASMA. The fusiform cells at
distance of these two areas were negative for ASMA
expression. At the remodelled stage, ASMA expression
was restricted to the cells in the tunica media of the
portal vessels (Figure 3). After 20 WD, a few fusiform
Figure 1
Alpha-smooth muscle actin (ASMA) expression in
normal fetal liver. At the ductal plate stage, all fusiform
cells in the portal stroma express ASMA (15 WD)
(V: portal vein; D: ductal plate).
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tracts near the hilum also expressed ASMA. Concerning
the lobular area, rare stained HSC were scattered in the
parenchyma (Figure 4); only 3 cases (3/28 cases),
respectively at the 13
th,1 6
th and 21
th WD, showed foci
of stained HSC. Cells around terminal venules near the
portal tract and fusiform cells around centrolobular
veins expressed ASMA (Figure 5). Hepatocytic cells were
not stained.
With double immunofluorescence using anti ASMA and
anti vimentin antibodies, negative ASMA fusiform cells
within the portal tract notably at the remodelled stage
expressed only vimentin (Figures 6 and 7). Endothelial
Figure 2
Alpha-smooth muscle actin (ASMA) expression in
normal fetal liver. At the remodelling stage, fusiform cells
at distance of the vessels and the biliary structures are ASMA
negative (13 WD) (V: portal vein; A: artery; B: bile duct).
Figure 3
Alpha-smooth muscle actin (ASMA) expression in
normal fetal liver. At the remodelled stage, ASMA
expression in portal tract is confined to the tunica media of
vessels (20 WD) (V: portal vein; A: artery; B: bile duct).
Figure 4
Alpha-smooth muscle actin (ASMA) expression in
normal fetal liver. Rare cells are stained with ASMA within
the lobule (23 WD) (C: centrolobular vein; P: portal tract).
Figure 5
Alpha-smooth muscle actin (ASMA) expression in
normal fetal liver. Second layer cells around the
centrolobular vein express ASMA, but not endothelial
cells (arrows) (23 WD).
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also stained, as previously described in adult liver [4,18].
h-Caldesmon
h-Caldesmon, a specific marker for the smooth muscle
cell differentiation last step [6,19], was expressed at 11
WD in the arterial tunica media of the hilum (Figure 8).
At the ductal plate stage, after the 11 WD, h-caldesmon
was not expressed in the future portal tracts. At the
remodelling stage, h-caldesmon expression was variably
present in fusiform cells of the arterial tunica media
(Figures 9 and 10). At the remodelled stage, all the cells
in the arterial tunica media were stained. Whatever the
stage, the other portal cells, as well as cells in the lobular
area, did not express h-caldesmon (Figure 11).
Cellular retinol-binding protein-1 (CRBP-1)
During portal tract development, portal mesenchymal
cells never expressed CRBP-1; in contrast biliary cells
regularly showed a granular cytoplasmic expression
(Figures 12 and 13). This cytoplasmic staining in biliary
cells was stronger than in fetal hepatocytes but lower
than in the stained cells of the Disse space. In lobular
area, until the 13
th WD, various number of CRBP-1
stained cells present in the Disse space was observed: no
cells in 2 cases, rare cells in 7 cases and numerous cells in
4 cases (Figure 14). After the 13
th WD, numerous stained
cells were present in all cases, excepted 2 cases where a
few cells were observed. Between the 16
th WD and the
18
th WD, numerous cytoplasmic processes were visible
in these CRBP-1 stained cells present in the Disse space.
Except in the oldest case, the density of stained cells was
lower than in the adult liver. All cases showed a low
cytoplasmic CRBP-1 staining in the hepatocytes and
canaliculi were often underlined by a reinforcement of
the CRBP-1 staining (Figure 15). Fusiform cells around
centrolobular veins expressed CRBP-1 (Figure 16).
Figure 6
Double immunofluorescence with ASMA (green)/
vimentin (red) in normal fetal liver.A tt h ed u c t a lp l a t e
stage, mesenchymal cells around portal vein express
ASMA (green) (13 WD).
Figure 7
Double immunofluorescence with ASMA (green)/
vimentin (red) in normal fetal liver. At the remodelled
stage, cells around portal vein and artery express ASMA
(green), and portal fibroblasts (arrows) express only
vimentin (red) (31 WD).
Figure 8
h-Caldesmon expression in normal fetal liver.A tt h e
early time of development, the arterial tunica media cells in
the hilum express h-caldesmon (arrow and left insert)
(11 WD).
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During the maturation of the portal tract, endothelial
cells of portal vessels, notably the terminal venules,
and centrolobular vein are stained (Figures 17, 18, 19
and 20). No portal mesenchymal cell, hepatocytic cell
and sinusoidal cell were stained.
Cytokeratin 19
The staining of the biliary cells depended of the level of
maturation. At the ductal plate stage, the cells of the
ductal plate began to express cytokeratin 19 (Figure 21).
During the remodelling of the ductal plate (Figure 22)
and at the remodelled stage (Figure 23), the biliary ducts
were regularly stained. As previously described [20],
Figure 9
h-Caldesmon expression in normal fetal liver.D u r i n g
the early time of the ductal plate remodelling, h-caldesmon is
not detected in cells around the portal arterial branch
(arrow) (11 WD).
Figure 10
h-Caldesmon expression in normal fetal liver.A t
advanced time in the remodelling stage, the arterial tunica
media cells express faintly h-caldesmon (double arrow, right
insert) or more strongly (single arrow, left insert) (13 WD).
Whatever the stage of portal tract maturation, interstitial
stromal cells are not stained.
Figure 11
h-Caldesmon expression in normal fetal liver. Around
the centrolobular cells, no h-caldesmon expression is found
(23 WD).
Figure 12
Cellular retinol-binding protein-1 (CRBP-1)
expression in normal fetal liver. At the beginning of the
remodelling stage, biliary structures express CRBP-1
stronger than hepatocytes. The portal stromal cells
are not stained (13 WD).
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the youngest cases. In all cases, all fibrocompetent cells
were not stained.
Fibrous fetal liver – Histology
At the beginning of the portal tract development, i.e.
ductal plate stage, there were no difference in the portal
tract morphology in all pathological livers and normal
fetal livers. At the end of the portal tract development,
portal tracts were enlarged by fibrosis (Figure 24) with
sometimes septa between portal tracts. The circumfer-
ential proliferation of bile ducts was low in IDS2,
moderate in MKS, and important with dilated bile ducts
in ARPKD. In all cases, portal tracts showed a
Figure 13
Cellular retinol-binding protein-1 (CRBP-1)
expression in normal fetal liver. At a late stage of the
remodelling stage, biliary structures express CRBP-1
stronger than hepatocytes. The portal stromal cells are not
stained (20 WD).
Figure 14
Cellular retinol-binding protein-1 (CRBP-1)
expression in normal fetal liver.N u m e r o u sH S C
express CRBP-1 in the parenchyma (11 WD).
Figure 15
Cellular retinol-binding protein-1 (CRBP-1)
expression in normal fetal liver. Around the sinusoid (S),
CRBP-1 stained HSC (double arrow) are present in the Disse
space (*), where haematopoiesis is observed. Hepatocytes
express also CRBP-1 with reinforcement in the canaliculi
(arrow) (11 WD).
Figure 16
Cellular retinol-binding protein-1 (CRBP-1)
expression in normal fetal liver. Second layer cells
around the centrolobular vein express CRBP-1 (11 WD).
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an increase in the number of hepatic artery branches. The
architecture of lobular parenchyma was unchanged.
Fibrous fetal liver – Immunohistochemistry
Alpha-smooth muscle actin (ASMA)
In the portal tract, the pattern of ASMA expression was
the same as in normal fetal liver at the beginning of
portal tract development. At the end of development,
when portal tracts were enlarged by fibrosis, numerous
fusiform cells surrounding the abnormal bile ducts were
stained as well as cells in vascular tunica media (Figure
25). In the lobular area, except in one case of MKS, cells
in the Disse space did not express ASMA. Fusiform cells
around centrolobular vein expressed ASMA.
Figure 17
CD34 expression in normal fetal liver.A tt h ed u c t a l
plate stage, only endothelial of the portal vein (V) or terminal
venules express CD34; portal mesenchymal cells as well as
ductal plate (arrows) are negative (11 WD).
Figure 18
CD34 expression in normal fetal liver.A tt h e
remodelling stage, endothelial of the portal vein (V), arteries
or terminal venules express CD34; portal mesenchymal cells
as well as biliary structures (arrows) are negative (11 WD).
Figure 19
CD34 expression in normal fetal liver.A tt h e
remodelled stage, endothelial of the portal vein (V), arteries
(A) or terminal venules express CD34; portal mesenchymal
cells as well as bile duct (arrow) are negative (13 WD).
Figure 20
CD34 expression in normal fetal liver. Around the
centrolobular vein, endothelial cells express CD34. The
second layer cells are negative (arrows) (23 WD).
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The evolution of h-caldesmon expression pattern was the
same as in the normal fetal liver: in all cases, only cells of
the arterial tunica media were stained (Figure 26).
Cellular retinol-binding protein-1 (CRBP-1)
In all cases, portal mesenchymal cells did not express
CRBP-1 (Figure 27). In lobular parenchyma, excepted for
3 cases, numerous HSC were stained and exhibited the
same pattern of CRBP-1 expression than HSC in the
normal fetal liver. CRBP-1 expression pattern of hepato-
cytes and of biliary cells was the same than in the normal
fetal liver.
CD34
As previously described [12], there are more stained
capillaries in the enlarged portal tracts than the normal
Figure 21
Cytokeratin 19 expression in normal fetal liver.A tt h e
ductal plate stage, ductal plate express cytokeratine
19 (11 WD).
Figure 22
Cytokeratin 19 expression in normal fetal liver.A tt h e
remodelling stage, biliary structures express cytokeratine
19 (11 WD).
Figure 23
Cytokeratin 19 expression in normal fetal liver.A tt h e
remodelled stage, biliary structures express cytokeratine
19 (11 WD).
Figure 24
A case of autosomal recessive polycystic kidney
disease. At a late stage of maturation, portal tract is
enlarged by fibrosis and contained numerous abnormal
bile ducts (trichrome staining)) (22 WD).
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fibrous septa and around the biliary structures (Figure
28). The fusiform mesenchymal cells in the portal tract
are not stained (Figure 28).
Cytokeratin 19
The staining of the biliary cells depended of the level of
maturation. In the beginning, the cells of the ductal
plates began to express cytokeratin 19. During the
abnormal remodeling of the ductal plate, the biliary
proliferation was regularly stained (Figure 29). In all
cases, cells in the Disse space were not stained.
Figure 25
Alpha-smooth muscle actin (ASMA) expression in a
case of autosomal recessive polycystic kidney disease.
As expected, vessels wall cells express ASMA. Abnormal bile
ducts are surrounded by ASMA positive stromal cells
(22 WD).
Figure 26
h-Caldesmon expression in a case of autosomal
recessive polycystic kidney disease.O n l ya r t e r i a lt u n i c a
media cells (arrow) express h-caldesmon.; ASMA positive
cells around abnormal bile ducts do not expressed
h-caldesmon (22 WD).
Figure 27
CRBP-1 expression in a case of autosomal recessive
polycystic kidney disease.P o r t a ls t r o m a lc e l l sd on o t
express CRBP-1 (22 WD).
Figure 28
CD34 expression in a case of autosomal recessive
polycystic kidney disease. Endothelial cells of the vessels
enmeshed in the enlarged portal tract, in the fibrous septa or
around the biliary structures express CD34; the portal
stromal cells do not expressed CD34 (arrow, left insert)
(22 WD).
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Our study explored the phenotypic heterogeneity of the
mesenchymal cells during liver development, mainly
along the portal tract tree in normal and in a large series
of fibrous fetal liver. For the first time, 3 markers, which
are expressed in hepatic stromal cells were used: ASMA, a
cytodifferentiated-related contractile protein expressed
notably by smooth muscle cells and myofibroblasts, and
2 others markers poorly used in fetal liver studies, h-
caldesmon (150 kDa caldesmon), an isotype of caldes-
mon expressed by smooth muscle cells, and CRBP-1
which is involved in vitamin A metabolism and is highly
expressed in HSC [3,6,9,19].
In the normal fetal liver, phenotypic changes of the
portal mesenchymal cells are observed during the 3
stages of the portal tract maturation. At the ductal plate
stage, all the mesenchymal cells expressed ASMA and did
not expressed CRBP-1 or h-caldesmon. At the remodel-
ling stage, a fibroblastic subpopulation of cells were
negative for the 3 markers cited above, but were positive
for vimentin, appeared in the middle area of the portal
tract at distance from vessels and biliary structures. At the
remodelled stage, only cells of arterial tunica media
expressed ASMA and h-caldesmon and displayed a
smooth muscle phenotype. The cells of portal vein
tunica media expressed ASMA, but not h-caldesmon. As
reported in adult liver, the connective tissue of the portal
tract contained fibroblastic cells, also called portal
fibroblasts, which expressed vimentin but not ASMA,
CRBP-1 or h-caldesmon [3,4]. During the maturation of
the portal tract in normal fetal liver, ASMA expressing
mesenchymal cells around future portal vein, called
myofibroblasts by Libbrecht et al. [12], were replaced or
could result from the differentiation into portal fibro-
blasts and contractile cells of the portal vein tunica
media. The sequential involvement of myofibroblastic
cells during fetal development was also observed in
other organs, notably in cardiac valve or lung [21,22].
Concerning the portal vein, we hypothesize that con-
tractile cells in the tunica media could achieve their
differentiation after the birth into smooth muscle cells
because, in adult normal liver, some cells present in the
thin tunica media of portal vein expressed h-caldesmon
(data not shown), a more specific and late marker of
smooth muscle cell differentiation [6]. We can speculate
that this maturation of portal vein smooth muscle cells is
related to the change of the portal venous circulation in
the liver at birth. Unlike portal vein, the tunica media
cells of the hepatic artery branches which were appeared
during the remodelling stage, were early completely
differentiated into smooth muscle cells, expressing
regularly ASMA as well as h-caldesmon. These smooth
muscle cells of the tunica media might take origin from
the tunica media cells of the upstream arteries. However,
we cannot exclude that they differentiate from the portal
myofibroblasts.
IDS2, MKS and ARPKD are autosomal recessively
inherited disorders characterised in the liver by abnor-
mal development of the portal tract and notably ductal
plate malformation [14-16]. In these diseases, the portal
tract stroma is enlarged by fibrosis and contained more
stromal cells. As described previously in one case of MKS
[17], we showed that, in all our pathological cases, a
myofibroblastic subpopulation, which expressed only
ASMA persists during all the abnormal maturation of the
portal tract and is condensed around the abnormal
biliary structures. These myofibroblasts which were
present in all portal tracts whatever the calibre of bile
ducts and not only in the larger-calibre septal bile ducts,
as seen in the normal liver until 2 years of age [12], were
probably responsible of the excessive deposition of
portal extracellular matrix. This myofibroblastic reaction
r e s e m b l e st h a ts e e ni nh u m a nl i v e rd i s e a s e sa f f e c t i n gb i l e
ducts or in experimental models such as bile duct
ligation. However, in these cases, myofibroblasts sur-
rounding the ductular proliferation seemed to derive
from the transdifferentiation of portal fibroblasts
[23-26].
In the lobular area, the development was the same in all
our normal and pathological cases. We showed that HSC
are present early in the Disse space and express CRBP-1.
The CRBP-1 staining showed that the thin cytoplasmic
processes are poorly developed in the beginning and
become more important later. CRBP-1 expressing HSC
Figure 29
Cytokeratin 19 expression in a case of autosomal
recessive polycystic kidney disease. Only biliary
structures express cytokeratin 19 (22 WD).
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release of retinoids [27]. As previously described, our
study in fetal liver showed that the number of CRBP-1
expressing HSC was variable but gradually increased
with the age of development [9,28]. As shown here,
CRBP-1 was also expressed all along the biliary tree from
canaliculi to extrahepatic bile duct; and this expression
was reinforced on the apical/luminale membrane. The
bile acid synthesis begins at about 5–9W Da n di t s
secretion at about 12 WD. Bile contains retinoids [29].
We assume that, besides the blood retinol transport,
there is a biliary transport of retinoids [3].
Conclusion
Our study shows that, during the portal tract develop-
ment, the portal mesenchymal cells are involved in a
morphological phenotypic shift from myofibroblasts to
portal fibroblasts and vascular smooth muscle cells; in
case of portal fibrosis following ductal plate malforma-
tion, portal myofibroblasts persist around the abnormal
biliary structures.
Methods
Human fetal liver specimens
Normal (28 cases, table 1) and pathological (11 cases,
table 2) human fetal tissues were obtained from
spontaneous or therapeutic/medical abortion performed
in compliance with the French legislation. The causes of
fetal death, sex, abnormalities after the autopsy and age
according to the date of last menstrual period were
summarized in tables 1 and 2. Developmental stages,
indicated in weeks after conception, were estimated from
the menstrual history and confirmed on anatomic
criteria using a regression equation for predicting fetal
age [30]. The procedures were in accordance with the
European Guidelines for the use of human tissues.
The tissue samples were routinely formalin fixed and
paraffin embedded; five μm-thick paraffin sections were
performed and stained with haematoxylin-eosin-saffron
(HES) for diagnosis purposes. Additional sections were
stained with Masson's trichrome or used for immuno-
histochemistry.
Immunohistochemistry
The immunohistochemical study was routinely per-
formed using an automated immunostainer (Dako A/S,
Glostrup, Denmark) with mouse monoclonal primary
antibodies against ASMA (1/100, Dako), CRBP-1 (1/100
[31]), h-caldesmon (1/50, Dako), CD34 (Dako), cyto-
keratine 7 (Dako), and cytokeratin 19 (Dako). The
epitopes were detected with the Envision+ system
horseradish peroxidase detection kit and revealed with
liquid diaminobenzidine (Dako).
For double immunofluorescence, slides were incubated
with mouse antibody against vimentin (1/800, Dako)
and rabbit antibody against ASMA (1/50, Abcam, Cam-
bridge, UK). Alexa Fluor 568 goat anti-mouse (1/200,
Invitrogen, Carlsbad, CA) and Alexa Fluor 488 goat anti-
rabbit (1/200, Invitrogen,) were used for the second step.
Sections were examined with a Zeiss Axioplan 2
microscope (Carl Zeiss Microscopy, Jena, Germany)
equiped with epiillumination and specific filters. Images
were acquired with an AxioCam camera (Carl Zeiss
Vision, Hallbergmoos, Germany) by means of the
AxioVision image processing and analysis system (Carl
Zeiss Vision).
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